Age-associated clonal B cells drive B cell lymphoma in mice.
José Pedro CastroAnastasia V ShindyapinaAlessandro BarbieriAlbert K YingOlga S StrelkovaJoao A PauloAlexander TyshkovskiyRico MeinlCsaba KerepesiAnna P PetrashenMarco MariottiMargarita V MeerYan HuAlexander KaramyshevGrigoriy LosyevMafalda GalhardoElsa LogarinhoArtur A IndzhykulianSteven P GygiJohn M SedivyJohn P ManisVadim N GladyshevPublished in: Nature aging (2024)
Although cancer is an age-related disease, how the processes of aging contribute to cancer progression is not well understood. In this study, we uncovered how mouse B cell lymphoma develops as a consequence of a naturally aged system. We show here that this malignancy is associated with an age-associated clonal B cell (ACBC) population that likely originates from age-associated B cells. Driven by c-Myc activation, promoter hypermethylation and somatic mutations, IgM + ACBCs clonally expand independently of germinal centers and show increased biological age. ACBCs become self-sufficient and support malignancy when transferred into young recipients. Inhibition of mTOR or c-Myc in old mice attenuates pre-malignant changes in B cells during aging. Although the etiology of mouse and human B cell lymphomas is considered distinct, epigenetic changes in transformed mouse B cells are enriched for changes observed in human B cell lymphomas. Together, our findings characterize the spontaneous progression of cancer during aging through both cell-intrinsic and microenvironmental changes and suggest interventions for its prevention.
Keyphrases